Back to top
more

Cigna Group (CI)

(Delayed Data from NYSE)

$358.58 USD

358.58
970,346

+9.74 (2.79%)

Updated Oct 16, 2024 04:00 PM ET

After-Market: $358.57 -0.01 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth C Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 6% (236 out of 250)

Industry: Medical - HMOs

Better trading starts here.

Zacks News

Centene Makes Investment in RxAdvance, Builds Partnership

Centene's (CNC) transformative alliance with RxAdvance is another instance of Health insurers joining forces with pharmacy benefit managers to reduce the costs in the drug supply chain.

    Cigna on Raters' Radar After Express Scripts Bid, Stock Down

    Cigna (CI) gets rating downgrade on a number of concerns related to the Express Scripts deal.

      Buy These 3 Stocks as Healthcare Continues to Shift Gears

      Mergers and acquisition in the healthcare industry should aid long term-growth for companies.

        Cigna to Take Over Express Scripts (ESRX) for $67 Billion

        Per a definitive agreement, Cigna will take over Express Scripts (ESRX) in a cash-and-stock transaction worth $67 billion.

          Cigna, Express Script Deal to Continue Healthcare Reshuffle

          Cigna's (CI) acquisition of Express Scripts should transform it into a more diversified entity.

            Hartford Financial to Buy Foremost Small Commercial Lines

            Hartford Financial's (HIG) acquisitions aim to improve its segmental performances.

              The Zacks Analyst Blog Highlights: Nordisk, TJX, Cigna, Regeneron and ArcelorMittal

              The Zacks Analyst Blog Highlights: Nordisk, TJX, Cigna, Regeneron and ArcelorMittal

                Anthem Buys America's 1st Choice, Expands in Medicare Market

                Anthem's (ANTM) acquisition of America's 1st Choice falls in line with its strategy to expand in the Medicare Advantage market.

                  MetLife (MET) Q4 Earnings Beat, Revenues Miss Estimates

                  Robust EMEA and Latin America segments aid MetLife (MET) in Q4. However, a dull performance at U.S., Asia and MetLife Holdings partially offsets this upside.

                    The Zacks Analyst Blog Highlights: Cigna, Burlington Stores and Anthem

                    The Zacks Analyst Blog Highlights: Cigna, Burlington Stores and Anthem

                      Benjamin Rains headshot

                      3 Stable Low-Beta Stocks to Buy During Volatile Markets

                      Markets began to rebound on Monday after their worst week in nearly two years. The Dow Jones Industrial Average and the S&P 500 both climbed over 1.30%. Still, analysts are divided over whether the recent sell-off is over just yet.

                        Cigna Q4 Earnings Top on Higher Enrollment, 2018 View Issued

                        Cigna (CI) Q4 earnings grow on higher revenues, which gained from higher premium and fees and increase in membership.

                          Cigna (CI) Beats on Q4 Earnings & Revenues, Guides for 2018

                          Cigna (CI) Q4 earnings gained on membership and revenue growth.

                            Will Higher Membership, Revenues Aid Cigna (CI) Q4 Earnings?

                            Cigna's (CI) Q4 earnings should likely be aided by higher revenues from its healthcare, global supplement units, partly offset by Medicare membership loss.

                              Zacks Industry Outlook Highlights: Aetna, Humana, Cigna and Anthem

                              Zacks Industry Outlook Highlights: Aetna, Humana, Cigna and Anthem

                                Zacks Industry Outlook Highlights: UnitedHealth, Humana, Cigna, Anthem and Centene

                                Zacks Industry Outlook Highlights: UnitedHealth, Humana, Cigna, Anthem and Centene

                                  Zacks Industry Outlook Highlights: Aetna, Cigna, UnitedHealth and CVS Health

                                  Zacks Industry Outlook Highlights: Aetna, Cigna, UnitedHealth and CVS Health

                                    Will Catastrophe Loss Impact Travelers' (TRV) Q4 Earnings?

                                    Weak underwriting results and deteriorated combined ratio across segments might affect Travelers' (TRV) Q4 results.

                                      3 Reasons Why Cigna (CI) is a Great Momentum Stock

                                      Cigna (CI )seems to be a great momentum stock on the back of favorable price performance both in short and long term.

                                        Why the Earnings Streak Will Continue for Cigna (CI)

                                        Cigna (CI) has seen a nice short-term history of beating earnings estimates, and looks poised to crush analyst expectations in its next earnings report as well.

                                          The Zacks Analyst Blog Highlights: Progressive, Cigna, Selective Insurance Group and Brighthouse Financial

                                          The Zacks Analyst Blog Highlights: Progressive, Cigna, Selective Insurance Group and Brighthouse Financial

                                            Invest in These 4 Insurance Stocks Ahead of Q4 Earnings

                                            We choose four insurers with favorable characteristics to leverage investors' portfolio ahead of Q4 earnings.

                                              Prudential (PRU) & Units' Ratings Retained by A.M. Best

                                              A.M. Best's rating action on Prudential (PRU) and its units reflects the company's solid operational efficiency, strong enterprise risk management, promising business profile and sturdy finances.

                                                MTG or RDN: Which Stock is Stronger for Mortgage Insurance?

                                                On a comparative-analysis basis, we try and find out which stock, Radian Group (RDN) or MGIC Investment (MTG), is better positioned in terms of fundamentals.

                                                  Tenet Healthcare Grows on Acquisitions, Lower Revenues Hurt

                                                  Tenet Healthcare (THC) gains from buyouts, divestitures and strategic initiatives. However, fall in revenues and high level of debt continue to bother.